{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:50:58Z","timestamp":1792759858193,"version":"4.5.0"},"reference-count":138,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Aspergillus can cause a spectrum of diseases depending on the immune status and predisposing conditions. Invasive pulmonary aspergillosis (IPA) is classically seen in patients with severe immunocompromise, such as patients with hematologic malignancies, transplant recipients, and chronic corticosteroid use at high doses. Recently, IPA cases in patients without these classic risk factors, including those associated with severe respiratory viral infections, chronic obstructive pulmonary disease, liver failure, and critical illness, are being increasingly recognized. Delayed recognition and missed diagnoses contribute to increased mortality in these patient populations. Maintaining a high index of suspicion and implementation of systematic screening protocols in high-risk patients may help reduce missed or delayed diagnoses and improve patient outcomes. This review describes the pathophysiology, incidence, risk factors, outcomes, and diagnostic and treatment considerations in IPA in patients with emerging risk factors.<\/jats:p>","DOI":"10.3390\/jof11080555","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T09:53:02Z","timestamp":1753696382000},"page":"555","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Emerging Risk Factors for Invasive Pulmonary Aspergillosis: A Narrative Review"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0705-1137","authenticated-orcid":false,"given":"Ahmed","family":"Elkhapery","sequence":"first","affiliation":[{"name":"Department of Medicine, Rochester General Hospital, Rochester, NY 14621, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Fatima","sequence":"additional","affiliation":[{"name":"Department of Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0262-4365","authenticated-orcid":false,"given":"Ayman O.","family":"Soubani","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e00140-18","DOI":"10.1128\/CMR.00140-18","article-title":"Aspergillus fumigatus and Aspergillosis in 2019","volume":"33","author":"Latge","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jhin.2007.06.008","article-title":"Ten-year air sample analysis of Aspergillus prevalence in a university hospital","volume":"67","author":"Falvey","year":"2007","journal-title":"J. Hosp. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/jhin.1999.0688","article-title":"Sampling of Aspergillus spores in air","volume":"44","author":"Morris","year":"2000","journal-title":"J. Hosp. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/bmj.1.4816.918","article-title":"Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy","volume":"1","author":"Rankin","year":"1953","journal-title":"BMJ"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3324\/haematol.2011.044636","article-title":"Invasive aspergillosis in patients with hematologic malignancies: Incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009","volume":"96","author":"Nicolle","year":"2011","journal-title":"Haematologica"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40121-017-0183-9","article-title":"Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review","volume":"7","author":"Bassetti","year":"2018","journal-title":"Infect. Dis. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13613-021-00923-4","article-title":"Risk factors for invasive aspergillosis in ICU patients with COVID-19: Current insights and new key elements","volume":"11","author":"Montrucchio","year":"2021","journal-title":"Ann. Intensive Care"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","article-title":"Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients","volume":"12","author":"Feys","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s15010-022-01960-2","article-title":"The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease","volume":"51","author":"Otu","year":"2023","journal-title":"Infection"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1128\/IAI.67.9.4563-4569.1999","article-title":"Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia","volume":"67","author":"Allen","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1128\/IAI.69.4.2037-2044.2001","article-title":"Interactions of surfactant proteins A and D with Saccharomyces cerevisiae and Aspergillus fumigatus","volume":"69","author":"Allen","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1128\/iai.65.8.3171-3179.1997","article-title":"Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages","volume":"65","author":"Madan","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2249.2007.03351.x","article-title":"Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis","volume":"148","author":"Kaur","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.4049\/jimmunol.174.11.6943","article-title":"Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SP-D gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigatus","volume":"174","author":"Madan","year":"2005","journal-title":"J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.4049\/jimmunol.181.10.7100","article-title":"Aspergillus conidia activate the complement by the mannan-binding lectin C2 bypass mechanism","volume":"181","author":"Lamy","year":"2008","journal-title":"J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature01195","article-title":"Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response","volume":"420","author":"Garlanda","year":"2002","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/iai.65.4.1510-1514.1997","article-title":"Internalization of Aspergillus fumigatus conidia by epithelial and endothelial cells","volume":"65","author":"Paris","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1128\/IAI.70.6.3156-3163.2002","article-title":"Uptake of Aspergillus fumigatus Conidia by phagocytic and nonphagocytic cells in vitro: Quantitation using strains expressing green fluorescent protein","volume":"70","author":"Wasylnka","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"30513","DOI":"10.1074\/jbc.M803149200","article-title":"Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1\/2 pathways and not by the toll-like receptor-MyD88 pathway","volume":"283","author":"Balloy","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/jlb.47.2.170","article-title":"Human neutrophil degranulation stimulated by Aspergillus fumigatus","volume":"47","author":"Levitz","year":"1990","journal-title":"J. Leukoc. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/iai.60.5.1747-1755.1992","article-title":"Specific binding of human fibrinogen fragment D to Aspergillus fumigatus conidia","volume":"60","author":"Annaix","year":"1992","journal-title":"Infect. Immun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1128\/iai.65.1.9-15.1997","article-title":"Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia","volume":"65","author":"Tronchin","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1080\/13693780500052099","article-title":"Cytokines in host defense against Aspergillus: Recent advances","volume":"43","author":"Phadke","year":"2005","journal-title":"Med. Mycol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4049\/jimmunol.162.3.1633","article-title":"Role of TNF-alpha in pulmonary host defense in murine invasive Aspergillosis","volume":"162","author":"Mehrad","year":"1999","journal-title":"J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1172\/JCI18125","article-title":"Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive Aspergillosis","volume":"112","author":"Morrison","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJMoa0802629","article-title":"Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation","volume":"359","author":"Bochud","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1128\/IAI.71.6.3034-3042.2003","article-title":"Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates","volume":"71","author":"Philippe","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/IAI.71.2.891-903.2003","article-title":"Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages","volume":"71","author":"Philippe","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis","volume":"22","author":"Dagenais","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.4049\/jimmunol.178.10.6367","article-title":"Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion","volume":"178","author":"Zarember","year":"2007","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1080\/13693780600897989","article-title":"Interactions of Aspergillus fumigatus with vascular endothelial cells","volume":"44","author":"Kamai","year":"2006","journal-title":"Med. Mycol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1309\/UJRV9DLC11RM3G8R","article-title":"Host-dependent patterns of tissue injury in invasive pulmonary Aspergillosis","volume":"127","author":"Stergiopoulou","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/IAI.73.1.494-503.2005","article-title":"Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary Aspergillosis","volume":"73","author":"Balloy","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1164\/ajrccm.152.3.7663787","article-title":"Pathogenesis of pulmonary Aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression","volume":"152","author":"Berenguer","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09059180.00001011","article-title":"Pulmonary Aspergillosis: A clinical review","volume":"20","author":"Kousha","year":"2011","journal-title":"Eur. Respir. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.1080\/13693780802227159","article-title":"Invasive Aspergillosis in glucocorticoid-treated patients","volume":"47","author":"Lewis","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1592\/phco.23.15.1592.31965","article-title":"Invasive Aspergillosis in patients with hematologic malignancies","volume":"23","author":"Wiederhold","year":"2003","journal-title":"Pharmacotherapy"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","article-title":"Invasive Aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors","volume":"100","author":"Marr","year":"2002","journal-title":"Blood"},{"key":"ref_41","unstructured":"Centers for Disease Control and Prevention (2025, July 02). Preliminary Estimated Flu Disease Burden 2024\u20132025 Flu Season, Available online: https:\/\/www.cdc.gov\/flu-burden\/php\/data-vis\/2024-2025.html."},{"key":"ref_42","unstructured":"Centers for Disease Control and Prevention (2025, July 02). COVID Data Tracker, Available online: https:\/\/covid.cdc.gov\/covid-data-tracker."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","article-title":"Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): A randomised, open-label, proof-of-concept trial","volume":"47","author":"Vanderbeke","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-2600(23)00408-3","article-title":"Risk factors for COVID-19-associated pulmonary Aspergillosis: A systematic review and meta-analysis","volume":"12","author":"Gioia","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: The French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3201\/eid2711.211174","article-title":"Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis(1)","volume":"27","author":"Janssen","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.202310-1815VP","article-title":"Fungal Fog in Viral Storms: Necessity for Rigor in Aspergillosis Diagnosis and Research","volume":"209","author":"Feys","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e3606","DOI":"10.1093\/cid\/ciaa1065","article-title":"Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients with COVID-19: A Prospective Study","volume":"73","author":"Bartoletti","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Feys, S., Almyroudi, M.P., Braspenning, R., Lagrou, K., Spriet, I., Dimopoulos, G., and Wauters, J. (2021). A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA). J. Fungi, 7.","DOI":"10.3390\/jof7121067"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S2213-2600(22)00259-4","article-title":"Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: An observational study","volume":"10","author":"Feys","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"eabq6682","DOI":"10.1126\/scitranslmed.abq6682","article-title":"A B1a-natural IgG-neutrophil axis is impaired in viral- and steroid-associated aspergillosis","volume":"14","author":"Sarden","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"105264","DOI":"10.1016\/j.micinf.2023.105264","article-title":"The influenza A virus promotes fungal growth of Aspergillus fumigatus via direct interaction in vitro","volume":"26","author":"Konig","year":"2024","journal-title":"Microbes Infect."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.chest.2023.09.019","article-title":"Prevalence, Risk Factors, Clinical Features, and Outcome of Influenza-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Systematic Review and Meta-Analysis","volume":"165","author":"Lu","year":"2024","journal-title":"Chest"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with COVID-19","volume":"384","author":"Group","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in Patients Hospitalized with COVID-19 Pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ergun, M., Bruggemann, R.J.M., Alanio, A., Delliere, S., van Arkel, A., Bentvelsen, R.G., Rijpstra, T., van der Sar-van der Brugge, S., Lagrou, K., and Janssen, N.A.F. (2021). Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients. J. Clin. Microbiol., 59.","DOI":"10.1128\/JCM.01229-21"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","article-title":"Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC\/MSGERC","volume":"72","author":"Alexander","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/cc3488","article-title":"Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: Risk factors, clinical presentation and outcome","volume":"9","author":"Leon","year":"2005","journal-title":"Crit. Care"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: Clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit. Care"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1439-0507.2011.02044.x","article-title":"Invasive fungal infections in the intensive care unit: A multicentre, prospective, observational study in Italy (2006\u20132008)","volume":"55","author":"Tortorano","year":"2012","journal-title":"Mycoses"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zhang, Z., Zhou, L., Lin, T., Zhang, R., Li, M., Chen, S., Liu, X., and Liu, X. (2025). Invasive aspergillosis in critically ill patients with diabetes mellitus: A systematic review and meta-analysis. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-10560-y"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Baddley, J.W., Stephens, J.M., Ji, X., Gao, X., Schlamm, H.T., and Tarallo, M. (2013). Aspergillosis in Intensive Care Unit (ICU) patients: Epidemiology and economic outcomes. BMC Infect. Dis., 13.","DOI":"10.1186\/1471-2334-13-29"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1053\/j.gastro.2024.08.046","article-title":"Immune Dysfunction and Infection Risk in Advanced Liver Disease","volume":"168","author":"McGettigan","year":"2025","journal-title":"Gastroenterology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1665-2681(19)30899-3","article-title":"The impact of bacterial infections on survival of patients with decompensated cirrhosis","volume":"13","author":"Strauss","year":"2013","journal-title":"Ann. Hepatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2004.12.005","article-title":"Paralysed monocytes in acute on chronic liver disease","volume":"42","author":"Antoniades","year":"2005","journal-title":"J. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2010.11.034","article-title":"Evidence of neutrophil functional defect despite inflammation in stable cirrhosis","volume":"55","author":"Tritto","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.1840060217","article-title":"Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis","volume":"6","author":"Rajkovic","year":"1986","journal-title":"Hepatology"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Lahmer, T., Brandl, A., Rasch, S., Baires, G.B., Schmid, R.M., Huber, W., and Mayr, U. (2019). Prevalence and outcome of invasive pulmonary aspergillosis in critically ill patients with liver cirrhosis: An observational study. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-48183-4"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13613-019-0502-2","article-title":"Invasive pulmonary aspergillosis in cirrhotic patients: Analysis of a 10-year clinical experience","volume":"9","author":"Levesque","year":"2019","journal-title":"Ann. Intensive Care"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/mmy\/myx011","article-title":"Invasive aspergillosis in patients with underlying liver cirrhosis: A prospective cohort study","volume":"55","author":"Prattes","year":"2017","journal-title":"Med. Mycol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2143\/ACB.3408","article-title":"Invasive aspergillosis in patients with cirrhosis, a case report and review of the last 10 years","volume":"68","author":"Jeurissen","year":"2013","journal-title":"Acta Clin. Belg."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/13693786.2010.535030","article-title":"Invasive aspergillosis in patients with liver disease","volume":"49","author":"Falcone","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/mmy\/myab044","article-title":"Invasive aspergillosis is a critical determinant of mortality in cirrhosis: A systematic review with meta-analysis","volume":"59","author":"Verma","year":"2021","journal-title":"Med. Mycol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Sharma, A., Mohamad, B., and Soubani, A.O. (2025). Epidemiology and Inpatient Outcomes of Invasive Aspergillosis in Patients with Liver Failure and Cirrhosis. J. Fungi, 11.","DOI":"10.3390\/jof11050334"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Hammond, E.E., McDonald, C.S., Vestbo, J., and Denning, D.W. (2020). The global impact of Aspergillus infection on COPD. BMC Pulm. Med., 20.","DOI":"10.1186\/s12890-020-01259-8"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: Incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1469-0691.2011.03503.x","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: A case control study from China","volume":"18","author":"Xu","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0256-4947.62828","article-title":"Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests","volume":"30","author":"Gao","year":"2010","journal-title":"Ann. Saudi Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1183\/09031936.00062206","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"30","author":"Bulpa","year":"2007","journal-title":"Eur. Respir. J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: Systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9343(92)90676-3","article-title":"Nonresolving pneumonia in steroid-treated patients with obstructive lung disease","volume":"93","author":"Rodrigues","year":"1992","journal-title":"Am. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"106720","DOI":"10.1016\/j.rmed.2021.106720","article-title":"Mortality outcomes associated with invasive aspergillosis among acute exacerbation of chronic obstructive pulmonary disease patient population","volume":"191","author":"Mir","year":"2022","journal-title":"Respir. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12931-021-01771-3","article-title":"A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"22","author":"Gu","year":"2021","journal-title":"Respir. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1479972307085637","article-title":"Invasive pulmonary aspergillosis in patients with COPD: A report of five cases and systematic review of the literature","volume":"5","author":"Samarakoon","year":"2008","journal-title":"Chron. Respir. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM200008243430818","article-title":"Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone","volume":"343","author":"Leav","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0953-6205(03)90006-9","article-title":"Inhaled corticosteroids in chronic obstructive pulmonary disease and disseminated aspergillosis","volume":"14","author":"Barouky","year":"2003","journal-title":"Eur. J. Intern. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/07853890.2018.1518581","article-title":"Invasive pulmonary aspergillosis in patients with solid tumours: Risk factors and predictors of clinical outcomes","volume":"50","author":"Dandachi","year":"2018","journal-title":"Ann. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1002\/cncr.24559","article-title":"Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: Retrospective analysis of 1711 lung cancer cases","volume":"115","author":"Yan","year":"2009","journal-title":"Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11046-018-0291-4","article-title":"Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature","volume":"184","author":"Oltolini","year":"2019","journal-title":"Mycopathologia"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2051-1426-2-19","article-title":"Opportunistic infections in patients treated with immunotherapy for cancer","volume":"2","author":"Kyi","year":"2014","journal-title":"J. Immunother. Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e00289","DOI":"10.1002\/rcr2.289","article-title":"Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab","volume":"6","author":"Uchida","year":"2018","journal-title":"Respirol. Case Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/cid\/ciw539","article-title":"The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma","volume":"63","author":"Romero","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(11)60839-2","article-title":"Fungal infections complicating tumor necrosis factor alpha blockade therapy","volume":"83","author":"Tsiodras","year":"2008","journal-title":"Mayo. Clin. Proc."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2007.083188","article-title":"Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: Meta-analyses of randomised placebo-controlled trials","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: Current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood. Cancer J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Garner, W., Samanta, P., and Haidar, G. (2021). Invasive Fungal Infections after Anti-CD19 Chimeric Antigen Receptor-Modified T-Cell Therapy: State of the Evidence and Future Directions. J. Fungi, 7.","DOI":"10.3390\/jof7020156"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/cid\/ciy152","article-title":"Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated with Chimeric Antigen Receptor T Cells","volume":"67","author":"Park","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2017-07-793760","article-title":"Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy","volume":"131","author":"Hill","year":"2018","journal-title":"Blood"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1182\/bloodadvances.2022007474","article-title":"Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma","volume":"6","author":"Little","year":"2022","journal-title":"Blood Adv."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"ofae133","DOI":"10.1093\/ofid\/ofae133","article-title":"The Burden of Invasive Fungal Disease Following Chimeric Antigen Receptor T-Cell Therapy and Strategies for Prevention","volume":"11","author":"Little","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Estella, A., Martin-Loeches, I., Nunez, M.R., Garcia, C.G., Pesaresi, L.M., Escors, A.A., Prieto, M.D.L., and Calvo, J.M.S. (2023). Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: A bronchoalveolar study. Ann. Clin. Microbiol. Antimicrob., 22.","DOI":"10.1186\/s12941-023-00626-7"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/509917","article-title":"Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign","volume":"44","author":"Greene","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinimag.2022.07.003","article-title":"CT findings of COVID-19-associated pulmonary aspergillosis: A systematic review and individual patient data analysis","volume":"90","author":"Hong","year":"2022","journal-title":"Clin. Imaging"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/myc.13274","article-title":"Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches","volume":"64","author":"Jenks","year":"2021","journal-title":"Mycoses"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2400803","DOI":"10.1183\/13993003.00803-2024","article-title":"Fungal lung disease","volume":"64","author":"Jaggi","year":"2024","journal-title":"Eur. Respir. J."},{"key":"ref_110","first-page":"1631","article-title":"Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison with Influenza-Associated Aspergillosis","volume":"224","author":"Lamoth","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.202208-1570OC","article-title":"A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis: The Proof Is in the Tissue","volume":"208","author":"Vanderbeke","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1164\/rccm.202306-1022ED","article-title":"Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization versus Infection?","volume":"208","author":"Albrich","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/JCM.01365-14","article-title":"PCR in diagnosis of invasive aspergillosis: A meta-analysis of diagnostic performance","volume":"52","author":"Arvanitis","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: The 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: An expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison with Antigen Testing","volume":"61","author":"White","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med."},{"key":"ref_119","first-page":"CD007394","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"2015","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.00345-17","article-title":"Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis","volume":"55","author":"Zhou","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2011-04-351601","article-title":"The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies","volume":"119","author":"Bergeron","year":"2012","journal-title":"Blood"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Zou, M., Tang, L., Zhao, S., Zhao, Z., Chen, L., Chen, P., Huang, Z., Li, J., Chen, L., and Fan, X. (2012). Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043347"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1473-3099(09)70019-2","article-title":"Use of PCR for diagnosis of invasive aspergillosis: Systematic review and meta-analysis","volume":"9","author":"Mengoli","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"562.e1","DOI":"10.1016\/j.cmi.2016.01.027","article-title":"Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patients","volume":"22","author":"Imbert","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Alexander","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1080\/13693780802308454","article-title":"Role of (1-->3)-beta-D-glucan in the diagnosis of invasive aspergillosis","volume":"47","author":"Marty","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/JCM.00506-08","article-title":"Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: Low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients","volume":"47","author":"Hachem","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/647942","article-title":"Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease","volume":"49","author":"Koo","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/JCM.02091-07","article-title":"Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections","volume":"46","author":"Persat","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1086\/588295","article-title":"Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years","volume":"46","author":"Obayashi","year":"2008","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/JCM.00879-11","article-title":"Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: An autopsy-based study","volume":"49","author":"Lagrou","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Ledoux, M.P., and Herbrecht, R. (2023). Invasive Pulmonary Aspergillosis. J. Fungi, 9.","DOI":"10.3390\/jof9020131"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e12751","DOI":"10.1111\/tid.12751","article-title":"Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4","volume":"19","author":"Groll","year":"2017","journal-title":"Transpl. Infect. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/339324","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: Increasing antigenemia is associated with progressive disease","volume":"34","author":"Boutboul","year":"2002","journal-title":"Clin. Infect. Dis."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/8\/555\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:49Z","timestamp":1760033809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/8\/555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,27]]},"references-count":138,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jof11080555"],"URL":"https:\/\/doi.org\/10.3390\/jof11080555","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,27]]}}}